perindoprilat has been researched along with angiotensin ii in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (64.29) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coetzee, WA; Enous, R; Opie, LH | 1 |
| Enous, R; Opie, LH | 1 |
| Henrion, D; Levy, BI; Qiu, HY | 1 |
| Dusting, GJ; Hickey, H; Hyland, R; Makdissi, M; Wilks, D | 1 |
| Gouyon, JB; Guignard, JP; Huet, F | 1 |
| Dinh, DT; Fabiani, ME; Story, DF | 1 |
| Kessler, KM; Kessler, RM | 1 |
| Bartels, GL; Remme, WJ; van den Heuvel, FM; van der Ent, M; van Veldhuisen, DJ | 1 |
| Barbe, F; Campbell, DJ; Crozatier, B; Hittinger, L; Su, JB | 1 |
| Aoka, Y; Aomi, S; Ishizuka, N; Kasanuki, H; Kawana, M; Koyanagi, H; Nagashima, H; Naruse, M; Ogawa, M; Sakomura, Y; Uto, K | 1 |
| Gouyon, JB; Guignard, JP; Huet, F; Prévot, A; Semama, DS | 1 |
| Boulanger, CM; Ebrahimian, T; Mathieu, E; Silvestre, JS | 1 |
| Castellani, WJ; Heffelfinger, S; Molteni, A; Moulder, JE; Uhal, B | 1 |
| Flavahan, NA; Flavahan, S; Leung, SW; Vanhoutte, PM; Xu, A; Zhao, Y | 1 |
1 review(s) available for perindoprilat and angiotensin ii
| Article | Year |
|---|---|
Potential deployment of angiotensin I converting enzyme inhibitors and of angiotensin II type 1 and type 2 receptor blockers in cancer chemotherapy.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Cells, Cultured; Humans; Indoles; Neoplasms; Prospective Studies; Radiation-Protective Agents; Retrospective Studies; Tumor Cells, Cultured | 2006 |
2 trial(s) available for perindoprilat and angiotensin ii
| Article | Year |
|---|---|
Acute anti-ischemic effects of perindoprilat in men with coronary artery disease and their relation with left ventricular function.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Cardiac Catheterization; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise Test; Humans; Indoles; Lactic Acid; Male; Middle Aged; Norepinephrine; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aorta; Aortic Diseases; Apoptosis; Cell Count; Cells, Cultured; Culture Media, Serum-Free; Female; Humans; Imidazoles; Indoles; Male; Marfan Syndrome; Middle Aged; Muscle, Smooth, Vascular; Pyridines; ras Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Thiazepines; Tunica Media | 2001 |
11 other study(ies) available for perindoprilat and angiotensin ii
| Article | Year |
|---|---|
Effects of the ACE inhibitor, perindoprilat, and of angiotensin II on the transient inward current of guinea pig ventricular myocytes.
Topics: Action Potentials; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channels; Guinea Pigs; Heart; In Vitro Techniques; Indoles; Ion Channels; Myocardium; Norepinephrine; Ouabain | 1992 |
Effect of the angiotensin-converting enzyme inhibitor, perindoprilat, and of angiotensin-II on the transient inward current of rabbit ventricular myocytes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Cells, Cultured; Electrophysiology; Heart Conduction System; Heart Ventricles; Indoles; Myocardial Contraction; Myocardium; Rabbits | 1994 |
Endogenous angiotensin II enhances phenylephrine-induced tone in hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Hypertension; Imidazoles; Indoles; Losartan; Mesenteric Arteries; Phenylephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regional Blood Flow; Tetrazoles; Vasomotor System | 1994 |
Perindopril treatment prevents the loss of endothelial nitric oxide function and development of neo-intima in rabbits.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Carotid Arteries; Disease Models, Animal; Endothelium, Vascular; Hemodynamics; In Vitro Techniques; Indoles; Nitric Oxide; Peptidyl-Dipeptidase A; Perindopril; Rabbits; Serotonin; Vasoconstriction; Vasodilation | 1996 |
Prevention of hypoxemia-induced renal dysfunction by perindoprilat in the rabbit.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Carbon Dioxide; Glomerular Filtration Rate; Hypoxia; Indoles; Kidney Diseases; Oxygen; Partial Pressure; Rabbits; Renal Circulation; Vasoconstriction | 1997 |
Interaction of the renin-angiotensin system, bradykinin and sympathetic nerves with cholinergic transmission in the rat isolated trachea.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Brimonidine Tartrate; Epithelium; Female; Idazoxan; In Vitro Techniques; Indoles; Indomethacin; Male; Neprilysin; Nitroarginine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Renin-Angiotensin System; Sympathetic Nervous System; Trachea | 1997 |
Angiotensin II and coronary sympathetic vasodilation.
Topics: Angiotensin II; Cardiovascular Agents; Drug Synergism; Humans; Indoles; Norepinephrine; Renin-Angiotensin System; Sympathetic Nervous System; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1998 |
Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Cardiac Output; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Enalaprilat; Heart Failure; Indoles; Norepinephrine; Peptide Fragments; Ventricular Function, Left | 1999 |
Complementary effects of adenosine and angiotensin II in hypoxemia-induced renal dysfunction in the rabbit.
Topics: Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Gas Analysis; Hypoxia; Indoles; Inulin; Kidney Diseases; Kidney Function Tests; Male; Rabbits; Renal Circulation; Theophylline; Vasoconstrictor Agents; Vasodilator Agents | 2002 |
Intraluminal pressure increases vascular neuronal nitric oxide synthase expression.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Carotid Artery, Common; Circadian Rhythm; Endothelium, Vascular; Indoles; Isoenzymes; Isometric Contraction; Male; Models, Animal; Models, Cardiovascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Tetrazoles; Time Factors; Vasoconstrictor Agents | 2003 |
Elevated pressure causes endothelial dysfunction in mouse carotid arteries by increasing local angiotensin signaling.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Carotid Arteries; Endothelium, Vascular; Hydrazines; Hypertension; Indoles; Losartan; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Reactive Oxygen Species; Signal Transduction; Tetrazoles; Valine; Valsartan; Vasodilation | 2015 |